These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2287054)

  • 1. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
    Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study on sulbactam/cefoperazone in urinary tract infections in elderly patients].
    Oyabu Y
    Jpn J Antibiot; 1996 Mar; 49(3):250-5. PubMed ID: 8935120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cefaclor in urinary tract infections (2)].
    Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
    Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with cefixime in urinary tract infections].
    Kameoka H; Takano Y; Miyoshi S; Iwao N; Mizutani S
    Jpn J Antibiot; 1989 Dec; 42(12):2540-7. PubMed ID: 2614911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of S 6472 in urinary tract infection].
    Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
    Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acute uncomplicated urinary tract infection in adults.
    Hooton TM; Stam WE
    Med Clin North Am; 1991 Mar; 75(2):339-57. PubMed ID: 1996038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of ceftriaxone administered once daily against pyelonephritis].
    Suzuki K; Horiba M; Nagata Y
    Hinyokika Kiyo; 1989 Jan; 35(1):159-65. PubMed ID: 2658512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA; Naber KG; Palou J; Elkharrat D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tract infection: economic considerations.
    Patton JP; Nash DB; Abrutyn E
    Med Clin North Am; 1991 Mar; 75(2):495-513. PubMed ID: 1996046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections.
    McDonald M; Kameh D; Johnson ME; Johansen TEB; Albala D; Mouraviev V
    Rev Urol; 2017; 19(4):213-220. PubMed ID: 29472825
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.